Valuation dashboard for KORU Medical Systems, Inc. (KRMD) with P/E N/A, P/B 8.02, EV/EBITDA -140.34 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems.
Analysis Summary
KORU Medical Systems, Inc. reported revenue of $41.1M in the most recent fiscal year, growing at a 5-year CAGR of 11.2%.
Trailing-twelve-month margins: gross margin 62.0%, operating margin -3.7%, net margin -4.0%.
At the current price of $3.22, KRMD has negative trailing earnings (P/E not meaningful) and an ROE of -10.63%. Market capitalisation stands at $148M.
Balance sheet quality for KRMD: current ratio of 2.4. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 8.02 |
| EV / EBITDA | -140.34 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-9.16 |
| vs Current Price | -384.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| KRMD | KORU Medical Systems, Inc. | $148M | 8.02 | -10.6% | |
| 0R29.L | Intuitive Surgical, Inc. | $137.6B | 74.97 | 12.01 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.5B | 44.28 | 7.65 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.3B | 33.07 | 2.18 | 6.6% |
| BDX | Becton, Dickinson and Company | $50.0B | 55.98 | 2.09 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.82 | 5.24 | 23.9% |
| 0KW4.L | ResMed Inc. | $32.5B | |||
| MDLN | Medline Inc. | $27.2B | 37.72 | 2.40 | 10.8% |
Price
| Price | $3.22 |
| Market Cap | $148M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -10.63% |
| Return on Invested Capital | -7.74% |
| Return on Assets | -6.51% |
| Gross Margin | 61.99% |
| Operating Margin | -3.66% |
| Net Margin | -4.03% |
Related companies: HIND · INFU · MXCT · NYXH · OSUR · PRE · PROF
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of KRMD: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks